Recent Reports


2010-01-25: Medical Research, Diagnostic Substances, Life Science Tools Report
7 leading Analysts; and top management from 2 Sector Firms examine this vital industry in this 38 page report from The Wall Street Transcript.
More Information
Order this Report

2009-12-07: Consumer Health Services Report
7 leading Analysts; and top management from 2 Sector Firm examine this vital industry in this 53 page report from The Wall Street Transcript.
More Information
Order this Report

2009-11-02: Pharmaceuticals Report
3 leading Analysts; and top management from 16 Sector Firms examine this vital industry in this 76 page report from The Wall Street Transcript.
More Information
Order this Report

2009-10-19: Biotechnology Report
3 leading Analysts; 2 Money Managers; and top management from 12 Sector Firms examine this vital industry in this 70 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Real Estate: Healthcare REITs, Long-Term Care Facilities & Hospitals Report
3 analysts and 6 sector firms examine the medical real estate segment in this 45 page report from The Wall Street Transcript.
More Information
Order this Report

09.21.09: Medical Devices Report
4 analysts and 7 sector firms examine the medical devices segment in this 41 page report from The Wall Street Transcript.
More Information
Order this Report

09.14.09: Medical Research Services Report
2 analysts, and 4 sector firms examine the medical research services segment in this 23 page report from The Wall Street Transcript.
More Information
Order this Report

Search TWST Online

TWST Newsletter

Give us your email address and receive the TWST Newsletter.


Company Interview Excerpt
SARAH GARVIN - DYNACQ INTERNATIONAL INC (DYII)


Full article published: 06/03/2002


For Subscribers

Get this article online now!

Order just this article
TWST: Can you please give a brief historical sketch of the company, as well as a picture of what you're doing at the present time?
Ms. Garvin: Dynacq is a health services company that is concentrated today in developing and operating healthcare facilities that provide primarily surgical services, both on an outpatient and an inpatient basis. The history of the company is that in 1992, it became publicly traded by virtue of a reverse merger with a shell. It concentrated in the early days on various types of outpatient health services. Then, as the company gained access to capital through its operations, it began in about 1996 to concentrate on first, outpatient surgical facilities, and then added inpatient facilities, in May of 1999.

TWST: Could you give us a sense of the health and the outlook of the industry at this time, and your placement in the competitive landscape?
Ms. Garvin: For investors who follow the proprietary, for-profit publicly-traded health service sector, it has been a decade long success story, albeit with ups and downs, for American and foreign investors. With the ongoing medical innovations that this country manages to develop, propel and put into practice, you have an increasingly high- tech health service industry with many ongoing opportunities for new corporate models. This is both because of the growth of the population in certain areas, as well as the replacement of older facilities. So I would say that the health service industry, which has never had a huge number of pure-service companies that are publicly traded, nonetheless is a significant factor in the market. We currently are looking at very bright prospects.

 

Tickers included in this excerpt: DYII

 

For more information call (212) 952 7433. The Wall Street Transcript does not endorse any of the comments made by interviewees, and does not make stock recommendations.